Searched for
CIVICA
Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growthBiocon Group reported a strong Q2 FY26 with a 20% year-on-year increase in operating revenue to Rs 4,296 crore, driven by biosimilars and g...- Game changer: California launches $11 state brand to slash Diabetes costsCalifornia is set to launch its own low cost insulin under the CalRx beginning from January 1, 2026, representing a major step in the state...
- Biocon Biologics expands collaboration with Civica to supply affordable insulin in USBiocon Biologics is expanding its partnership with Civica. This new agreement will bring affordable Insulin Glargine to patients in the Uni...
- Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
- Could Trump’s proposed pharmaceutical tariffs trigger a drug shortage in the U.S.?On April 8, President Trump announced that his administration would soon implement a “major tariff on pharmaceuticals” imported into the U....
- Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the USBiocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will supply the insu...
- Bank stress tests prove strength: EUEuropean Union "stress tests" on the bloc's banks prove that the EU financial sector is sound because just seven out of 91 lenders - five o...
Load More